Holding Asks CMS for Reconsideration on Step Therapy

US Representative George Holding recently sent a letter to the Centers for Medicare and Medicaid Services (CMS) Administrator Seema Verma asking for reconsideration of the recent notification that Medicare Advantage plans will no longer be prohibited from using step therapy for Part B drugs.

“Given the potential impact on patient access and care, I believe CMS should pause on moving forward with this policy in 2019,” Holding wrote.

Read the letter.

 
 

Share this Post